Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.30) by 16.67 percent. This is a 16.67 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $52.57 million which beat the analyst consensus estimate of $52.07 million by 0.96 percent. This is a 2.86 percent increase over sales of $51.11 million the same period last year.